These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23043626)

  • 1. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer.
    Odeh F; Ismail SI; Abu-Dahab R; Mahmoud IS; Al Bawab A
    Drug Deliv; 2012 Nov; 19(8):371-7. PubMed ID: 23043626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
    Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
    Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.
    Fahmy HM
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1465-1476. PubMed ID: 31377882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M
    Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone-Loaded Soluplus
    Bergonzi MC; Vasarri M; Marroncini G; Barletta E; Degl'Innocenti D
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice.
    Ong YS; Saiful Yazan L; Ng WK; Noordin MM; Sapuan S; Foo JB; Tor YS
    Int J Nanomedicine; 2016; 11():5905-5915. PubMed ID: 27877037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles.
    Abu-Dahab R; Odeh F; Ismail SI; Azzam H; Al Bawab A
    Pharmazie; 2013 Dec; 68(12):939-44. PubMed ID: 24400439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and anti-breast cancer activity of (-)-antofine carried with liposomes].
    Wu DM; Chen Y; Wu L
    Zhong Yao Cai; 2013 Sep; 36(9):1511-4. PubMed ID: 24620699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer.
    Kommineni N; Saka R; Bulbake U; Khan W
    Chem Phys Lipids; 2019 Nov; 224():104707. PubMed ID: 30521787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis.
    Velho-Pereira R; Kumar A; Pandey BN; Jagtap AG; Mishra KP
    Cell Biol Int; 2011 Oct; 35(10):1025-9. PubMed ID: 21557727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
    Liu Y; Luo X; Xu X; Gao N; Liu X
    Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
    Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
    Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines.
    Shariare MH; Khan MA; Al-Masum A; Khan JH; Uddin J; Kazi M
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
    Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
    Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Avicequinone-B formulations: Aqueous solubility, physicochemical properties and apoptotic effects on cutaneous squamous cell carcinoma cells.
    Hu SC; Su YS; Lai YC; Tseng CH; Yen FL
    Phytomedicine; 2019 May; 58():152870. PubMed ID: 30903942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles.
    Noor NS; Kaus NHM; Szewczuk MR; Hamid SBS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.